catechin and irinotecan

catechin has been researched along with irinotecan in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's1 (14.29)24.3611
2020's3 (42.86)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Graber, AY; Innocenti, F; Komoroski, BJ; Mirkov, S; Ramírez, J; Ratain, MJ; Strom, SC1
Chen, TC; Hofman, FM; Lee, AS; Pyrko, P; Schönthal, AH1
Lin, LC; Tsai, TH; Wang, MN1
Ben Lagha, A; Grenier, D; Vaillancourt, K1
Chen, D; Chen, L; Dong, J; Geng, R; Gou, H; Liu, J; Ren, S; Wu, W; Xiang, B; Yang, X; Zhang, Z1
Bharali, MK; Borah, G1

Other Studies

7 other study(ies) available for catechin and irinotecan

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Effects of green tea compounds on irinotecan metabolism.
    Drug metabolism and disposition: the biological fate of chemicals, 2007, Volume: 35, Issue:2

    Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Catechin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Glucuronates; Glucuronosyltransferase; Hepatocytes; Humans; Hydroxytestosterones; Irinotecan; RNA, Messenger; Tea

2007
The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas.
    Cancer research, 2007, Oct-15, Volume: 67, Issue:20

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Caspase 7; Catechin; Cell Growth Processes; Cell Line, Tumor; Dacarbazine; Down-Regulation; Drug Screening Assays, Antitumor; Drug Synergism; Endoplasmic Reticulum Chaperone BiP; Fluorouracil; Glioblastoma; Heat-Shock Proteins; Humans; Irinotecan; Molecular Chaperones; RNA, Small Interfering; Temozolomide; Transcription Factor CHOP; Transfection

2007
Food-drug interaction of (-)-epigallocatechin-3-gallate on the pharmacokinetics of irinotecan and the metabolite SN-38.
    Chemico-biological interactions, 2008, Aug-11, Volume: 174, Issue:3

    Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Area Under Curve; Bile; Biological Transport; Camptothecin; Catechin; Chromatography, High Pressure Liquid; Contraindications; Dietary Supplements; Food-Drug Interactions; Glucuronides; Injections, Intravenous; Irinotecan; Male; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms

2008
A green tea extract and epigallocatechin-3-gallate attenuate the deleterious effects of irinotecan in an oral epithelial cell model.
    Archives of oral biology, 2021, Volume: 126

    Topics: Catechin; Epithelial Cells; Irinotecan; Plant Extracts; Tea

2021
EGCG synergizes the therapeutic effect of irinotecan through enhanced DNA damage in human colorectal cancer cells.
    Journal of cellular and molecular medicine, 2021, Volume: 25, Issue:16

    Topics: Antioxidants; Autophagy; Catechin; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colorectal Neoplasms; DNA Damage; Drug Synergism; Drug Therapy, Combination; Humans; Irinotecan; Topoisomerase I Inhibitors

2021
Green tea catechins in combination with irinotecan attenuates tumorigenesis and treatment-associated toxicity in an inflammation-associated colon cancer mice model.
    Journal of the Egyptian National Cancer Institute, 2021, Jul-26, Volume: 33, Issue:1

    Topics: Animals; Carcinogenesis; Catechin; Colonic Neoplasms; Humans; Inflammation; Irinotecan; Mice; Tea

2021